Summit Therapeutics (SMMT) stock price and chart
SMMT: price 17.59, 24h change +0.23%, 24h turnover $1.2M. Perpetual on a stock, venue BingX. Updated in real time.
What this is
Company stockSummit Therapeutics is a biotech that bet everything on one drug: ivonescimab, a bispecific antibody against lung cancer, licensed from China's Akeso. The company compares it head-to-head with Keytruda, the world's best-selling cancer drug. What this shows: for a one-molecule biotech the chart lives on trial dates rather than revenue — between them the price moves on rumour, and on results day it can halve or double.
Chart
Chart built from data of BingX
What the data shows
SMMT trades at 17.59. Over 57 days it ranged between 12.07 and 19.92; the price now sits in the upper third of that range — 70% of the way from the yearly low to the high.
All-time high is 19.92 (September 2026); the price is 12% below it now.
The daily range is 0.2% and five-minute NATR is 0.00%. That range is at percentile 12 for the year — a noticeably calmer day than usual.
Open positions in SMMT are worth $920K. Over the past hour open interest rose by 0.00%. That is at percentile 12 over three weeks: noticeably fewer positions than usual.
Traded on a single venue — BingX. There is nothing to cross-check the price against, so a drift from the wider market would go unseen.
This is a contract on a stock. It trades around the clock, while the share itself trades only during its exchange hours: overnight and at weekends the price is held by expectation, not by trades in the stock.
Funding is -0.0040%: shorts pay longs, so positioning leans to sellers.
24-hour turnover is $1.2M — percentile 51 for the year: a normal level of activity for it.
SMMT correlation with Bitcoin over 24 hours is 0.40 — it partly moves with the market.
Over the day +0.23%, over the hour 0.00%, over the last five minutes 0.00% — it moved livelier an hour ago and has since gone quiet.
By turnover it ranks 963 of 2044 instruments in the screener.
By daily range it ranks 1941 of 2044.
Built from current numbers and the coin's own year of history. Updates with the data.
Our observations
KairoRight now SMMT is within its usual range: volume, funding and open interest are all unremarkable.
Computed from our own minute history for this coin over a year. Percentile is the share of days the value was below today's. Description only, no forecasts.
What we noticed earlier
Similar instruments
From the same group — company stock. They open the same way, with a chart and a breakdown.
Price and movement
Turnover and activity
Futures metrics
How to read this
- Funding is a payment between longs and shorts. A positive rate means longs pay shorts: the market is crowded long.
- The rate rank shows how unusual that rate is for this particular coin: 97 means above 97% of the last month, a rare skew. Without the rank the bare number says nothing — every coin has its own normal.
- Open interest is the money sitting in positions that are still open. Rising alongside price means new money entering; rising while price falls means shorts building up.
- The OI rank is measured in contracts rather than dollars: otherwise it would drift up with price alone and claim a record where nothing changed.
- NATR shows how much a coin moves relative to its own price. High NATR with high turnover is where today's action is.
How much money sits in open positions on each venue. The total spans every exchange listing the contract.